Defensive Medicine is liability exposure pushes clinicians to order tests for legal protection rather than clinical need. It sits in the Incentives dimension (INC) of the Human Behavior Taxonomy™ as element HBT-INC-0092, within the Healthcare Perverse Pattern family. The core principle: liability exposure pushes clinicians to order tests for legal protection rather than clinical need. In incentive terms, it matters because it changes the payoff people perceive before they choose — which means it can be designed for, or exploited.
Scientific Definition
Liability exposure pushes clinicians to order tests for legal protection rather than clinical need.
Plain-English Definition
Liability exposure pushes clinicians to order tests for legal protection rather than clinical need.
Feynman Explanation
When the lawyer is your real customer, the patient is the byproduct.
Core Principle
Liability exposure pushes clinicians to order tests for legal protection rather than clinical need.
Mechanisms
Pending editorial review.
Liability exposure pushes clinicians to order tests for legal protection rather than clinical need.
Pending editorial review.
Pending editorial review.
Liability regimes shape clinical workflow more than guidelines do.
Pending editorial review.
Pending editorial review.
Inputs (Triggers)
Pending editorial review.
Outputs (Behaviors)
Pending editorial review.
Behavioral Signature
When the lawyer is your real customer, the patient is the byproduct.
Examples
- Reflexive CT scans for low-risk head bumps.
- Liability regimes shape clinical workflow more than guidelines do.
Pending editorial review.
Original analysis from The Incentives Lab — how this element behaves inside real payoff structures.
Why this element matters to incentive design
Most organizations meet this element as a personnel problem. It is not one. The mechanism underneath it is straightforward: liability exposure pushes clinicians to order tests for legal protection rather than clinical need. You can recognize it in the field by its signature: when the lawyer is your real customer, the patient is the byproduct. Every element in the Incentives dimension changes the perceived payoff of an action before the action happens, which is exactly where incentive design has leverage.
How it gets exploited
Left undesigned, liability regimes shape clinical workflow more than guidelines do. It is amplified whenever liability regimes shape clinical workflow more than guidelines do. Inside organizations that shows up as liability regimes shape clinical workflow more than guidelines do. The pattern is the same one Goodhart's Law describes: the measurable proxy attracts the effort, and the purpose behind it quietly loses funding.
How the Lab designs around it
The redesign move is to safe-harbor frameworks. Outcome-tied liability reform. Watch for it at the boundaries: handoffs, promotions, incident reviews, and budget cycles are where this element gets its power.
Famous Experiments
Pending editorial review.
Design Principles
- Safe-harbor frameworks. Outcome-tied liability reform.
Measurement Approaches
Pending editorial review.
Evidence
Pending editorial review.
Pending editorial review.
The Perverse Incentive Lens™
How this behavior is exploited — and how to redesign around it.
- Safe-harbor frameworks. Outcome-tied liability reform.
Pending editorial review.
Pending editorial review.
Interactive Mini Network
Click any neighbor to re-center the graph and follow the threads of connection.
Knowledge Graph Neighbors
Auto-linked to the rest of the Human Behavior Taxonomy by family, domain, dimension, and shared keywords.
Productivity targets compress visits, raising misdiagnosis and burnout.
A federal mandate intended to lower drug costs for the poor became a profit engine for hospitals and contract pharmacies.
Federal reimbursement rules incentivize cycling seniors through hospitalizations to upgrade billing categories.
Paying providers per procedure rewards more procedures, not better outcomes.
Systems paid per filled bed have weak incentives to invest in prevention or community health.
Opaque billing rules create lucrative work for administrators and revenue-cycle firms instead of care.
Insurers profit when claims are denied, delayed, or abandoned.
Hospital group-purchasing and opaque contracting inflate device costs far above marginal cost.
Sales bonuses and prescriber relationships fueled mass over-prescription and an addiction crisis.
Federal incentives meant for neglected diseases get used to privatize widely available medicines.
Drug companies optimize for high-margin chronic conditions, not cures.
Specialists earn more for procedures than primary care for prevention.
Where Defensive Medicine is cited in the corpus
Essays, field guides, and diagnostics from The Incentives Lab that apply this element.
- Field guideIncentives: definition, types, examples
The parent field guide for this element.
- ReferenceThe laws of incentives
Goodhart, Campbell, and the Cobra Effect.
- CourseIncentives 101
The free ten-part primer on reading a payoff structure.
- ReferenceThe incentive glossary
Definitions for every mental model, bias, and fallacy in the corpus.
- ReferenceThe Periodic Table of Human Behavior
The full 1,267-element map this page belongs to.
Questions about Defensive Medicine
- What is Defensive Medicine?
- Defensive Medicine is liability exposure pushes clinicians to order tests for legal protection rather than clinical need. It sits in the Incentives dimension (INC) of the Human Behavior Taxonomy™ as element HBT-INC-0092, within the Healthcare Perverse Pattern family. The core principle: liability exposure pushes clinicians to order tests for legal protection rather than clinical need. In incentive terms, it matters because it changes the payoff people perceive before they choose — which means it can be designed for, or exploited.
- What is an example of Defensive Medicine?
- Liability regimes shape clinical workflow more than guidelines do. The Incentives Lab catalogs everyday, organizational, and historical instances of this element on its Human Behavior Taxonomy™ page (HBT-INC-0092).
- How is Defensive Medicine exploited?
- Liability regimes shape clinical workflow more than guidelines do.
- How do you design around Defensive Medicine?
- Safe-harbor frameworks. Outcome-tied liability reform.
- Which behavioral dimension does Defensive Medicine belong to?
- Defensive Medicine is classified in the Incentives dimension (INC) of the Human Behavior Taxonomy™, family "Healthcare Perverse Pattern", class "Perverse Incentive". Its permanent identifier is HBT-INC-0092 and its evidence grade is C.